Sugammadex versus neostigmine by measuring postoperative recovery of breathing muscle strength using ultrasound in robotic assisted uterus removal surgery in women.

Comparison of Sugammadex and Neostigmine for Postoperative Recovery of Respiratory Muscle Strength Measured by Ultrasonography in Robotic Assisted Total Hysterectomy - Nil

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/01/100588

Enrollment

Registered

2026-01-08

Start date

Unknown

Completion date

Unknown

Last updated

2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: T818- Other complications of procedures,not elsewhere classified Health Condition 2: T811- Postprocedural shock

Interventions

Intervention1: Inj sugammadex: Inj sugammadex 2mg per kg made to volume of 10ml Control Intervention1: Inj neostigmine: Inj neostigmine 0.005mg per kg made to volume 10ml

Eligibility

Inclusion criteria

Inclusion criteria: Female patients posted for robotic assisted total hysterectomy. Patients with American Society of Anaesthesiology ASA class 1 or 2.

Exclusion criteria

Exclusion criteria: Patient with history of allergy to test drugs. Patient with neuromuscular disease.

Design outcomes

Primary

Measure	Time frame
Post operative recovery of expiration muscle strength by measuring Internal oblique muscle thickening fraction in mm.Timepoint: Baseline that is pre induction then at time of extubation then at 15 minutes and 30 minutes after extubation	—

Secondary

Measure	Time frame
Post operative recovery of inspiration muscle strength by measuring diaphragm excursion in mm.Timepoint: Baseline that is pre induction then at time of extubation then at 15 minutes and 30 minutes after extubation	—

Countries

India

Contacts

Public ContactDr Sakshi Synghal

sakshis23354@gmail.com7297000466

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026